We have previously reported that the Ca2+-chelating agent BAPTA abolished the CXCL12-induced, but not the EGF-induced, GBM cell chemotaxis, suggesting that the efficacy of GBM invasiveness might be related to an array of non-overlapping mechanisms activated by different chemotactic agents [25]. This evidence concerns the gene EGF and glioblastoma.